The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease
Open accessAbstract
BACKGROUND: Lyme disease is a multisystem inflammatory disease caused by infection with the tick-borne spirochete Borrelia burgdorferi and is the most common vector-borne infection in the United States. We assessed the efficacy of a recombinant vaccine consisting of outer-surface protein A (OspA) without adjuvant in subjects at risk for Lyme disease. METHODS: For this double-blind trial, 10,305 subjects 18 years of age or older were recruited at 14 sites in areas of the United States where Lyme disease was endemic; the subjects were randomly assigned to receive either placebo (5149 subjects) or 30 microg of OspA vaccine (5156 subjects). The first two injections were administered 1 month apart, and 7515 subjects also received a booster dose at 12 months. The subjects were observed for two seasons during which the risk of transmission of Lyme disease was high. The primary end point was the number of new clinically and serologically confirmed cases of Lyme disease. RESULTS: The efficacy of the vaccine was 68 percent in the first year of the study in the entire population and 92 percent in the second year among the 3745 subjects who received the third injection. The vaccine was well tolerated. There was a higher incidence of mild, self-limited local and systemic reactions in the vaccine group, but only during the seven days after vaccination. There was no significant increase in the frequency of arthritis or neurologic events in vaccine recipients. CONCLUSIONS: In this study, OspA vaccine was safe and effective in the prevention of Lyme disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Protection of Mice Against the Lyme Disease Agent by Immunizing with Recombinant OspA
Fikrig, E., Barthold, S. W., Kantor, F. S., & Flavell, R. A. (1990) · Science · doi:10.1126/science.2237407 · Cited by 488
A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
Szmuness, W., Stevens, C. E., Zang, E. A., Harley, E. J., & Kellner, A. (1981) · Hepatology · doi:10.1002/hep.1840010502 · Cited by 457
Kalish, R. A., Leong, J. M., & Steere, A. C. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2774-2779.1993 · Cited by 299
Schaible, U. E., Kramer, M. D., Eichmann, K., Modolell, M., Museteanu, C., & Simon, M. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3768 · Cited by 273
Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA
Erdile, L. F., Brandt, M. A., Warakomski, D. J., Westrack, G. J., Sadziene, A., Barbour, A. G., & Mays, J. P. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.81-90.1993 · Cited by 179
Self-citationSimon, M. M., Schaible, U. E., Kramer, M. D., Eckerskorn, C., Museteanu, C., Muller-Hermelink, H. K., & Wallich, R. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.1.123 · Cited by 173
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice
Fikrig, E., Barthold, S. W., Marcantonio, N., Deponte, K., Kantor, F. S., & Flavell, R. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.657-661.1992 · Cited by 167
LYME DISEASE:A Review of Aspects of Its Immunology and Immunopathogenesis
Sigal, L. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.63 · Cited by 147
Self-citationThe Prevalence and Incidence of Clinical and Asymptomatic Lyme Borreliosis in a Population at Risk
Fahrer, H., van der Linden, S., Sauvain, M. J., Gern, L., Zhioua, E., & Aeschlimann, A. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.2.305 · Cited by 143
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Self-citationStanek, G., Wormser, G. P., Gray, J., & Strle, F. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60103-7 · Cited by 1,237
Molecular Mimicry and Autoimmunity
Albert, L. J., & Inman, R. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412707 · Cited by 516
Steinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 501
Metadata
- Authors
- Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., & Marks, D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-07-23
- Volume
- 339
- Issue
- 4
- Pages
- 216-222
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2337700516
- Cited by
- 397
- References
- 22
- FWCI
- 39.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. https://app.cochat.ai/papers/10.1056/nejm199807233390402
- The paper
- Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., & Marks, D. (1998). A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm199807233390402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.